FDA Places Partial Clinical Hold on CTI BioPharma's (CTIC) Pacritinib IND
Tweet Send to a Friend
CTI BioPharma Corp. (CTI BioPharma) (Nasdaq: CTIC) announced that the Company received written communication from the U.S. Food and Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
